113 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
regarding related drugs, deem such studies appropriate. The purpose of such studies would be to assess a known serious risk or signals of serious risk … , such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose
8-K
EX-4.1
c5ei vrt7hv9ucobw
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
8-K
EX-1.1
tbm1k
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
40t4uuckjnhqkm
9 Feb 24
Prospectus supplement with pricing info
5:14pm